Peptide Express Launches Independently HPLC-Verified Research Peptide Catalog

Peptide Express has launched an expanded catalog of 30+ research-grade peptides, each independently tested by third-party laboratories for 99%+ purity.

United States, 13th Jul 2026 - Peptide Express has announced the launch of its expanded catalog of research-grade peptides, built for laboratories, academic institutions, and independent researchers who require verifiable documentation of compound identity and purity.

The platform gives researchers access to more than 30 research compounds, each independently tested by third-party laboratories using High-Performance Liquid Chromatography (HPLC) and LC-MS/MS analysis. There is no self-reported purity data to take on faith, no separate request process for documentation, and no delay between order and evidence. Every batch is verified before it ships, and a batch-specific Certificate of Analysis (CoA) is included automatically with every order.

Quality assurance is built into the ordering process itself. Researchers select a compound, and the associated CoA, purity percentage, and lab verification data are attached to that specific batch, not a general product listing. This batch-level traceability means the documentation a researcher receives corresponds to the exact vial in their hands, not an average or a representative sample.

Each compound listing supports full transparency into testing method and result, giving researchers the flexibility to review purity data before committing to an order. This makes it straightforward to compare compounds, verify specifications against internal lab standards, and maintain audit-ready records for institutional or grant-funded research.

Consistency is supported through independent, third-party verification at every stage. Rather than relying on internal quality claims, every batch is tested by outside laboratories, and the resulting CoA gives researchers a documented reason to trust what is in the vial before it reaches the bench.

Every order flows directly into a streamlined fulfilment process. Researchers receive fast, temperature-controlled shipping, sealed packaging designed to preserve compound stability, and full CoA documentation with no post-order follow-up required. The result is a research supply process built on verifiable data from the first order, with all products intended strictly for in-vitro laboratory research and educational use.
About Peptide Express
Peptide Express is an online supplier of research-grade peptides for laboratory and educational use. All compounds are independently HPLC-verified by third-party laboratories to a guaranteed purity of 99%+, with a Certificate of Analysis provided for every batch sold. All products are intended solely for in-vitro laboratory research and are not for human or animal consumption.

Peptide Express2847 Corporate Center Drive, Suite 210

Austin, Texas 78744

United States

+1 512-555-0142

Contact Details

Organization: Peptide Express

Contact Person: Peter Dewall

Website: https://peptide.express/

Email: Send Email [https://dashboard.kingnewswire.com/release-contact/47024]

Country: United States

Release Id: 13072647024

The post Peptide Express Launches Independently HPLC-Verified Research Peptide Catalog appeared first on King Newswire. This content is provided by a third-party source. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the 'Media Contact' section above.

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. king Newswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact support@kingnewswire.com

This release was published on openPR.